These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22046351)

  • 1. Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.
    Manunta MD; McAnulty RJ; Tagalakis AD; Bottoms SE; Campbell F; Hailes HC; Tabor AB; Laurent GJ; O'Callaghan C; Hart SL
    PLoS One; 2011; 6(10):e26768. PubMed ID: 22046351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer.
    Tagalakis AD; McAnulty RJ; Devaney J; Bottoms SE; Wong JB; Elbs M; Writer MJ; Hailes HC; Tabor AB; O'Callaghan C; Jaffe A; Hart SL
    Mol Ther; 2008 May; 16(5):907-15. PubMed ID: 18388925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes.
    Birchall JC; Kellaway IW; Gumbleton M
    Int J Pharm; 2000 Mar; 197(1-2):221-31. PubMed ID: 10704809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway deposition of nebulized gene delivery nanocomplexes monitored by radioimaging agents.
    Manunta MD; McAnulty RJ; McDowell A; Jin J; Ridout D; Fleming J; Bottoms SE; Tossici-Bolt L; Laurent GJ; Biassoni L; O'Callaghan C; Hart SL
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):471-80. PubMed ID: 23614789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
    Davies LA; Nunez-Alonso GA; McLachlan G; Hyde SC; Gill DR
    Hum Gene Ther Clin Dev; 2014 Jun; 25(2):97-107. PubMed ID: 24865497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro.
    Stern M; Sorgi F; Hughes C; Caplen NJ; Browning JE; Middleton PG; Gruenert DC; Farr SJ; Huang L; Geddes DM; Alton EW
    Gene Ther; 1998 May; 5(5):583-93. PubMed ID: 9797862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer.
    Yoshimura K; Rosenfeld MA; Nakamura H; Scherer EM; Pavirani A; Lecocq JP; Crystal RG
    Nucleic Acids Res; 1992 Jun; 20(12):3233-40. PubMed ID: 1377820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo.
    Jiang C; O'Connor SP; Fang SL; Wang KX; Marshall J; Williams JL; Wilburn B; Echelard Y; Cheng SH
    Hum Gene Ther; 1998 Jul; 9(11):1531-42. PubMed ID: 9694152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
    Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
    PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium.
    Perricone MA; Morris JE; Pavelka K; Plog MS; O'Sullivan BP; Joseph PM; Dorkin H; Lapey A; Balfour R; Meeker DP; Smith AE; Wadsworth SC; St George JA
    Hum Gene Ther; 2001 Jul; 12(11):1383-94. PubMed ID: 11485630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Alton EWFW; Armstrong DK; Ashby D; Bayfield KJ; Bilton D; Bloomfield EV; Boyd AC; Brand J; Buchan R; Calcedo R; Carvelli P; Chan M; Cheng SH; Collie DDS; Cunningham S; Davidson HE; Davies G; Davies JC; Davies LA; Dewar MH; Doherty A; Donovan J; Dwyer NS; Elgmati HI; Featherstone RF; Gavino J; Gea-Sorli S; Geddes DM; Gibson JSR; Gill DR; Greening AP; Griesenbach U; Hansell DM; Harman K; Higgins TE; Hodges SL; Hyde SC; Hyndman L; Innes JA; Jacob J; Jones N; Keogh BF; Limberis MP; Lloyd-Evans P; Maclean AW; Manvell MC; McCormick D; McGovern M; McLachlan G; Meng C; Montero MA; Milligan H; Moyce LJ; Murray GD; Nicholson AG; Osadolor T; Parra-Leiton J; Porteous DJ; Pringle IA; Punch EK; Pytel KM; Quittner AL; Rivellini G; Saunders CJ; Scheule RK; Sheard S; Simmonds NJ; Smith K; Smith SN; Soussi N; Soussi S; Spearing EJ; Stevenson BJ; Sumner-Jones SG; Turkkila M; Ureta RP; Waller MD; Wasowicz MY; Wilson JM; Wolstenholme-Hogg P;
    Lancet Respir Med; 2015 Sep; 3(9):684-691. PubMed ID: 26149841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.
    Alton EW; Stern M; Farley R; Jaffe A; Chadwick SL; Phillips J; Davies J; Smith SN; Browning J; Davies MG; Hodson ME; Durham SR; Li D; Jeffery PK; Scallan M; Balfour R; Eastman SJ; Cheng SH; Smith AE; Meeker D; Geddes DM
    Lancet; 1999 Mar; 353(9157):947-54. PubMed ID: 10459902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
    N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.
    Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME
    J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for cystic fibrosis by means of aerosol.
    Rochat T; Morris MA
    J Aerosol Med; 2002; 15(2):229-35. PubMed ID: 12184873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Gill DR; Southern KW; Mofford KA; Seddon T; Huang L; Sorgi F; Thomson A; MacVinish LJ; Ratcliff R; Bilton D; Lane DJ; Littlewood JM; Webb AK; Middleton PG; Colledge WH; Cuthbert AW; Evans MJ; Higgins CF; Hyde SC
    Gene Ther; 1997 Mar; 4(3):199-209. PubMed ID: 9135733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
    Copreni E; Penzo M; Carrabino S; Conese M
    Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.